Innovative 'Immune Digital Twins' Pave the Way for Safer Drug Testing and Personalized Medicine
An international research initiative is developing 'immune digital twins'—virtual models of the human immune system—that can predict individual responses to treatments, potentially revolutionizing personalized medicine and drug safety.
An ambitious international initiative is underway to develop 'immune digital twins'—virtual, dynamic models of the human immune system—that can simulate how individuals respond to various drugs and treatments. Led by the Research Data Alliance Building Immune Digital Twins Working Group (RDA-BIDT WG), which includes over 100 experts from 22 countries and is chaired by Professor Anna Niarakis of the University of Toulouse, this project aims to address longstanding challenges in immunology and infectious disease management.
Digital twins, which are sophisticated virtual representations of physical systems, have already proven successful in engineering and industries. In healthcare, their applications include cardiovascular diagnostics and diabetes management systems like artificial pancreas devices. Extending this concept, the immune digital twin offers a groundbreaking approach to personalized medicine: enabling clinicians and researchers to predict how with a specific patient's immune system might react to therapy without exposing the patient to potential risks.
Creating an immune digital twin is highly complex because the human immune system is a highly intricate and adaptable network of cells and molecules. Accurately capturing a person's immune state in real time faces hurdles such as data incompatibility and the challenge of integrating diverse data types. To overcome these obstacles, the project fosters collaboration among immunologists, clinicians, computational biologists, engineers, and ethicists, emphasizing a transdisciplinary approach.
The overarching goal of the RDA is to establish a social and technical infrastructure that reduces barriers to data sharing, fueling progress in personalized immunology. This initiative represents a crucial step toward safer, more effective treatments and a deeper understanding of immune responses. For more details, refer to the publication by Niarakis et al., titled 'Building Immune Digital Twins: An International and Transdisciplinary Community Effort' (ImmunoInformatics, 2025).
source: https://medicalxpress.com/news/2025-10-immune-digital-twins-simulate-drug.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Brain Shape Alterations as Early Indicators of Dementia
New research reveals that changes in brain shape with age may serve as early indicators of dementia, providing potential for earlier diagnosis and intervention through advanced geometric analysis.
Breakthrough Research Offers Hope for New Treatments in Juvenile Dermatomyositis
Innovative research uncovers mitochondrial dysfunction and immune system overactivity in juvenile dermatomyositis, paving the way for targeted therapies for affected children.
WHO Confirms No Evidence of Harm from Vaccine Ingredient Opposed by US Panel
The World Health Organization affirms the safety of thimerosal, a vaccine preservative, amid recent US panel opposition. Extensive research shows no harm, reaffirming its vital role in global immunization efforts.
Breakthrough in Understanding Rare Multi-Organ Disease Unveils New Pathways for Treatment
Researchers have identified mutations in the SPNS1 gene as the cause of a rare multi-organ disease, paving the way for targeted therapeutic strategies and improved patient outcomes.